(PDF) Target Blood Concentrations of CYA and Tacrolimus in

Target Blood Concentrations of CYA and Tacrolimus in Randomized Controlled Trials for the Prevention of Acute GVHD After Hematopoietic SCT

Bone Marrow Transplantation - United Kingdom

doi 10.1038/bmt.2009.213

Full Text

Abstract

Available in full text

Categories

Transplantation

Date

August 24, 2009

Authors

Publisher

Springer Science and Business Media LLC

Related search

Decreased Insulin Secretion in Patients Receiving Tacrolimus as GVHD Prophylaxis After Allogeneic Hematopoietic SCT

Bone Marrow Transplantation

Transplantation

English

Visilizumab With Tacrolimus and Methotrexate for GvHD Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors

Bone Marrow Transplantation

Transplantation

English

Prevention of GVHD After Blood Transfusion.

Journal of the Japan Society of Blood Transfusion

English

A Randomized Controlled Trial of Cyclosporine and Tacrolimus With Strict Control of Blood Concentrations After Unrelated Bone Marrow Transplantation

Bone Marrow Transplantation

Transplantation

English

Chronic GVHD Induced GVL Effect After Unmanipulated Haploidentical Hematopoietic SCT for AML and Myelodysplastic Syndrome

Bone Marrow Transplantation

Transplantation

English

CsA Exposure Is Associated With Acute GVHD and Relapse in Children After SCT

Bone Marrow Transplantation

Transplantation

English

Frequency of CD4+FOXP3+ Regulatory T-Cells at Early Stages After HLA-mismatched Allogeneic Hematopoietic SCT Predicts the Incidence of Acute GVHD

Bone Marrow Transplantation

Transplantation

English

Therapeutic Hypothermia and Prevention of Acute Kidney Injury: A Meta-Analysis of Randomized Controlled Trials

Emergency Nursing

Emergency Medicine

Cardiovascular Medicine

English

Predictors of Overall Survival Among Patients Treated With Sirolimus/Tacrolimus vs Methotrexate/Tacrolimus for GvHD Prevention

Bone Marrow Transplantation

Transplantation

English